Table 2.
Groups | Patients, n(%) | GG | GT | TT |
---|---|---|---|---|
Cancer | ||||
ERβ–positive |
698/855 (81.64) |
226 /265 (85.28) |
350 /410 (85.37) |
122/180 (67.78) |
Fibroadenoma | ||||
ERβ–positive |
550/628 (87.58) |
205/235 (87.23) |
266/304 (87.50) |
79/89 (88.76) |
OR |
0.631 |
0.848 |
0.858 |
0.266 |
CI 95% |
0.470–0.846 |
0.508–1.415 |
0.556–1.324 |
0.129–0.552 |
p value | 0.002 | 0.528 | 0.49 | <0.001 |